相关实验视频

Updated: Jun 24, 2025

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

普埃拉林通过向JAK2/STAT3信号通路来缓解大鼠的骨质疏松症

Xinlei Zhao¹, Jiaxuan Zhou¹, Yanqing Liu²

¹Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, The Inner Mongolia Autonomous Region, China; Department of Orthopaedic Surgery, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, The Inner Mongolia Autonomous Region, China.

Biomolecules & biomedicine

|June 6, 2024

概括

在骨质疏松症模型中,Puerarin (Pue) 治疗改善了骨密度,并减少了骨质损失. 它增强了骨形成标记物,并抑制了JAK2/STAT3通路,这表明了骨质疏松症的新型治疗方法.

科学领域:

生物医学科学生物医学科学
药理学药理学是指药理学的学科.
整形外科整形外科整形外科

背景情况:

骨质疏松症 (OP) 是一种普遍的骨疾病,特别是在绝经后的妇女中,导致骨折风险增加.
普埃拉林 (Pue) 显示出作为OP有效治疗的潜力.

研究的目的:

在大鼠模型中研究瑞林 (Pue) 对绝经后骨质疏松症 (PMOP) 的治疗作用.
阐明PMOP治疗中Pue作用的潜在机制.

主要方法:

在Sprague-Dawley大鼠中通过卵巢切除诱导了绝经后的骨质疏松症,随后进行了Pue治疗.
评估了骨矿物质密度 (BMD),大腿骨结构 (Micro-CT) 和血清骨标记物 (OC,BALP,PINP通过ELISA).
在骨组织中,Janus kinase 2/信号传感器和转录3激活器 (JAK2/STAT3) 途径的激活使用西式斑点评价.

主要成果:

皮埃治疗显著改善了骨矿物质密度,并减少了骨损失.
骨质素 (OC) 和骨性酸酶 (BALP) 的血清水平增加,表明骨质生成增强.
Pue治疗导致腿骨组织中JAK2/STAT3信号通路的激活减少.

结论:

普埃拉林 (Pue) 显示出治疗绝经后骨质疏松症 (PMOP) 的治疗潜力.
促进骨质生成并抑制JAK2/STAT3信号通路,为其抗骨质疏松作用提供了潜在的机制.

更多相关视频

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention

Published on: April 26, 2024

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...